A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR): Toxicity evaluation Meeting Abstract
| Authors: | Neal, J. W.; Pennell, N. A.; Goodgame, B. W.; Lanuti, M.; Heist, R. S.; Shaw, A. T.; Temel, J. S.; Janne, P. A.; Azzoli, C. G.; Sequist, L. V. |
| Abstract Title: | A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR): Toxicity evaluation |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 533s |
| Language: | English |
| ACCESSION: | WOS:000208852004621 |
| DOI: | 10.1200/jco.2010.28.15_suppl.7078 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7078 -- S -- Source: Wos |
